ad image

Celgene

1 / 1
Immatics

Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies

Immatics

Strategic CollaborationSep 03, 2019
Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case
Legal

Celgene to pay Mylan $62 Million to Resolve Cancer Drug Antitrust Case

Nice Insight

PR-M08-19-NI-007Aug 02, 2019
Celgene Corporation
Financial Report

Celgene Reports Second Quarter 2019 Operating and Financial Result

Celgene Corporation

PR-M08-19-NI-003Aug 01, 2019
Celgene Corporation
FDA Approval

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

Celgene Corporation

PR-M07-19-NI-068Jul 25, 2019
Nimbus Therapeutics
Alliance

Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology

Nimbus Therapeutics

PR-M07-19-NI-027Jul 11, 2019
Bristol-Myers Squibb
M&A

Bristol-Myers Squibb Provides Update on Pending Merger with Celgene

Bristol-Myers Squibb

PR-M06-19-NI-051Jun 26, 2019
BMS–Celgene Merger Still On
M&A

BMS–Celgene Merger Still On

Nice Insight

PAO-M05-19-NI-007May 02, 2019
Evotec
Collaboration

Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines

Evotec

PR-M06-18-NI-002Jun 01, 2018
Evotec
Strategic Partnership

Evotec and Celgene Enter into Strategic Oncology Partnership

Evotec

PR-M05-18-NI-091May 24, 2018
1 / 1